Abstract
Recently, the efficiency of anticancer therapeutics is increasingly measured by their potential to eliminate a subpopulation of tumor cells, the so called tumorigenic stem cells (TSC). Also in medulloblastoma (MB), the most malignant embryonal brain tumor, such TSC were identified by expression of CD133 or CD15. In previous studies we could show a radioadditive effect of the demethylating agent 5-aza-2'deoxycytidin (5-aza-dC) on the clonogenic survival of human MB cells. Now we aim to clarify whether 5-aza-dC and irradiation (IR) have similar effects on the TSC subpopulation. In addition we applied resveratrol (RV), to see if combination of above treatments with this differentiation inducer may further reduce the clonogenic potential of MB cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
